What are the main manufacturers of Ocriplasmin?

Ocriplasmin (Ocriplasmin) is a biological enzyme preparation used to treat vitreous-macular adhesion and small macular holes. Its original drug was developed by Thrombogenics NV, a biopharmaceutical company headquartered in Belgium that focuses on innovative treatments for ophthalmic diseases. Thrombogenics transformed Jetrea from laboratory research into a clinically available drug through years of research and development, ensuring the drug meets strict standards in terms of purity, activity and stability.

In addition to the original manufacturerThrombogenics, Jetrea’s distribution in the global market involves multiple regional agents and cooperative companies. For example, for the US market, Thrombogenics cooperates with Alcon Laboratories for sales and promotion; in some European countries, it also achieves drug listing and supply through local partners. During the production process, the company strictly abides by GMP standards to ensure the enzyme activity, sterility and stability of each batch of drugs to ensure that patients receive safe and controllable therapeutic effects during the injection process.

It is worth noting that, so far, there is no generic version of Oakplasmin officially launched on the market. This means that patients can only rely on the originator drug and its authorized supply channels when obtaining medicines. This centralized production model helps ensure drug quality, but it also results in relatively high prices and limits accessibility to the domestic market. While providing drugs, manufacturers also provide medication guidance, injection training and patient support plans to help clinicians carry out treatment safely and standardizedly.

In general, the main manufacturer of Oak plasmin is BelgiumThrombogenics NV. Global distribution relies on regional partners. The quality and safety of the drugs are strictly controlled to ensure that they are stable and effective in clinical use. Understanding manufacturer information is very important for patients to obtain genuine drugs and use them rationally.

Reference materials:https://www.drugs.com/cdi/ocriplasmin.html